234 related articles for article (PubMed ID: 3085598)
21. Immune complex and complement-mediated leukocyte recruitment in bullous pemphigoid.
Gammon WR
Immunol Ser; 1989; 46():509-25. PubMed ID: 2488868
[No Abstract] [Full Text] [Related]
22. 97 kDa linear IgA bullous dermatosis antigen localizes in the lamina lucida between the NC16A and carboxyl terminal domains of the 180 kDa bullous pemphigoid antigen.
Ishiko A; Shimizu H; Masunaga T; Yancey KB; Giudice GJ; Zone JJ; Nishikawa T
J Invest Dermatol; 1998 Jul; 111(1):93-6. PubMed ID: 9665393
[TBL] [Abstract][Full Text] [Related]
23. [Bullous pemphigoid].
Ohyama M; Amagai M
Ryoikibetsu Shokogun Shirizu; 2000; (31):274-6. PubMed ID: 11269078
[No Abstract] [Full Text] [Related]
24. Human autoantibodies against the 230-kD bullous pemphigoid antigen (BPAG1) bind only to the intracellular domain of the hemidesmosome, whereas those against the 180-kD bullous pemphigoid antigen (BPAG2) bind along the plasma membrane of the hemidesmosome in normal human and swine skin.
Ishiko A; Shimizu H; Kikuchi A; Ebihara T; Hashimoto T; Nishikawa T
J Clin Invest; 1993 Apr; 91(4):1608-15. PubMed ID: 7682575
[TBL] [Abstract][Full Text] [Related]
25. Rat bladder epithelium: a sensitive substrate for indirect immunofluorescence of bullous pemphigoid.
Delmonte S; Cozzani E; Drosera M; Parodi A; Rebora A
Acta Derm Venereol; 2000 May; 80(3):175-8. PubMed ID: 10954206
[TBL] [Abstract][Full Text] [Related]
26. Anatomical distribution and immunological characteristics of epidermolysis bullosa acquisita antigen and bullous pemphigoid antigen.
Furue M; Iwata M; Tamaki K; Ishibashi Y
Br J Dermatol; 1986 Jun; 114(6):651-9. PubMed ID: 3521710
[TBL] [Abstract][Full Text] [Related]
27. Pemphigoid nodularis: a case with 230 kDa hemidesmosomes antigen associated with bullous pemphigoid antigen.
Tamada Y; Yokochi K; Oshitani Y; Nitta Y; Ikeya T; Hara K; Owaribe K
J Dermatol; 1995 Mar; 22(3):201-4. PubMed ID: 7738277
[TBL] [Abstract][Full Text] [Related]
28. Bullous pemphigoid sera that contain antibodies to BPAg2 also contain antibodies to LABD97 that recognize epitopes distal to the NC16A domain.
Egan CA; Taylor TB; Meyer LJ; Petersen MJ; Zone JJ
J Invest Dermatol; 1999 Feb; 112(2):148-52. PubMed ID: 9989788
[TBL] [Abstract][Full Text] [Related]
29. Detection of IgG autoantibodies in the sera of patients with bullous and gestational pemphigoid: ELISA studies utilizing a baculovirus-encoded form of bullous pemphigoid antigen 2.
Haase C; Büdinger L; Borradori L; Yee C; Merk HF; Yancey K; Hertl M
J Invest Dermatol; 1998 Mar; 110(3):282-6. PubMed ID: 9506450
[TBL] [Abstract][Full Text] [Related]
30. Immediate hypersensitivity phenomena in bullous pemphigoid: critical concepts.
Bowszyc-Dmochowska M; Dmochowski M
J Med; 2002; 33(1-4):189-98. PubMed ID: 12939118
[TBL] [Abstract][Full Text] [Related]
31. In situ-bound antibodies eluted from the skin of patients with bullous pemphigoid are preferentially directed against the 230-kD bullous pemphigoid antigen.
Korman NJ
J Invest Dermatol; 1995 Dec; 105(6):824-30. PubMed ID: 7490478
[TBL] [Abstract][Full Text] [Related]
32. Pyodermatitis-pyostomatitis vegetans with circulating autoantibodies to bullous pemphigoid antigen 230.
Ahn BK; Kim SC
J Am Acad Dermatol; 2004 May; 50(5):785-8. PubMed ID: 15097967
[TBL] [Abstract][Full Text] [Related]
33. Ramipril-associated lichen planus pemphigoides.
Ogg GS; Bhogal BS; Hashimoto T; Coleman R; Barker JN
Br J Dermatol; 1997 Mar; 136(3):412-4. PubMed ID: 9115928
[TBL] [Abstract][Full Text] [Related]
34. Bullous pemphigoid sera react specifically with various domains of BP230, most frequently with C-terminal domain, by immunoblot analyses using bacterial recombinant proteins covering the entire molecule.
Hamada T; Nagata Y; Tomita M; Salmhofer W; Hashimoto T
Exp Dermatol; 2001 Aug; 10(4):256-63. PubMed ID: 11493314
[TBL] [Abstract][Full Text] [Related]
35. Identification of a 160-kD molecule as a component of the basement membrane zone and as a minor bullous pemphigoid antigen.
Zhu XJ; Niimi Y; Bystryn JC
J Invest Dermatol; 1990 Jun; 94(6):817-21. PubMed ID: 1693941
[TBL] [Abstract][Full Text] [Related]
36. A case of bullous pemphigoid successfully treated by plasmapheresis: assessment of the change in titers of circulating antibodies by immunoblotting and enzyme-linked immunosorbent assay.
Lee JB; Fumimori T; Kurose K; Mori O; Hashimoto T
J Dermatol; 2003 Apr; 30(4):326-31. PubMed ID: 12707470
[TBL] [Abstract][Full Text] [Related]
37. Bullous pemphigoid antigen localization suggests an intracellular association with hemidesmosomes.
Westgate GE; Weaver AC; Couchman JR
J Invest Dermatol; 1985 Mar; 84(3):218-24. PubMed ID: 2579167
[TBL] [Abstract][Full Text] [Related]
38. Lichen planus pemphigoides with IgG autoantibodies to the 180 kd bullous pemphigoid antigen (type XVII collagen).
Hsu S; Ghohestani RF; Uitto J
J Am Acad Dermatol; 2000 Jan; 42(1 Pt 1):136-41. PubMed ID: 10607335
[TBL] [Abstract][Full Text] [Related]
39. Concurrence of autoantibodies to bullous pemphigoid antigens and desmoglein 3: analysis of pathogenic and nonpathogenic antibodies.
Ono S; Tanioka M; Tanizaki H; Fujisawa A; Koga H; Hashimoto T; Kamiya K; Aoyama Y; Iwatsuki K; Miyachi Y
Br J Dermatol; 2013 Jun; 168(6):1357-60. PubMed ID: 23738642
[No Abstract] [Full Text] [Related]
40. Bullous pemphigoid-like eruption subsequent to scabies: bullous scabies or bullous pemphigoid?
Huang MX; Li ZS; Luo DQ; Lin Q
G Ital Dermatol Venereol; 2015 Jun; 150(3):337-9. PubMed ID: 25658439
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]